Gitnux/Report 2026

Weight Losing Industry Statistics

The global weight-management market is estimated at $221.7 billion in 2026, explore the weight losing figures on growth, companies and trends.
33Statistics
31Sources
5Sections
1Visuals
17mRead
How this report is researched
01Editorial Scope

Gitnux editors write the brief first: the topic, the inclusion rules, and the frame for what belongs.

02Source Research

Agents search the published record and log every extracted figure back to the passage it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 32 days

01 Industry overview

The weight losing industry at a glance

The global weight-management industry is estimated at $221.7 billion in 2026, driven by GLP-1 medicines, diet products, digital programs and rising demand for obesity treatment.

$221.7B[4]
2026 market estimate
14.2%[4]
2026–2033 forecast CAGR
35.0%[4]
Asia-Pacific share in 2025
$36.5B[17]
Top obesity-drug sales in 2025
Market size
The global weight-management market was valued at $190.6 billion in 2025 and is estimated at $221.7 billion in 2026. The market includes diet products, fitness and surgical equipment, slimming and consultation services, and online weight-loss programs.[4]
Forecast & CAGR
Grand View Research forecasts the market to reach $562.2 billion by 2033, implying a 14.2% CAGR from 2026 to 2033. Mordor Intelligence separately forecasts GLP-1 prescription therapies to grow at a 15.2% CAGR through 2031.[4][1]
Market share & regions
Asia-Pacific held the largest regional share at 35.0% of global revenue in 2025 in Grand View Research’s estimate. Mordor Intelligence instead places North America first at 34.7% in 2025, showing that regional rankings vary with market definitions and methodologies.[4][1]
Segmentation
Diet products accounted for more than 70% of global revenue in 2025 according to Grand View Research. Mordor Intelligence estimates diet-based food and beverages held 34.7% of the market, while weight loss as a consumer goal represented 47.2%.[4][1]
Key players & concentration
The prescription-drug segment is led by Eli Lilly and Novo Nordisk. Eli Lilly reported 2025 revenue of $22.965 billion for Mounjaro and $13.542 billion for Zepbound, while Novo Nordisk said its obesity portfolio reached 3.6 million people worldwide and grew 31% at constant exchange rates in 2025.[18][19]
Pricing
Reliable, comparable global consumer pricing data were not identified. Eli Lilly reported that lower realized prices partly offset 2025 U.S. revenue growth for Mounjaro and Zepbound, while CDC reporting identified cost and insurance coverage as important barriers to prescribed GLP-1 use.[18][20]
Trends, drivers & challenges
Growth is being driven by obesity prevalence, GLP-1 adoption, digital weight-management programs, bariatric surgery and higher health awareness. Key challenges include cost, limited insurance coverage, shortages and unregulated compounded products; CDC data found that about two in five U.S. GLP-1 users modified use from the prescribed regimen, often because of cost or availability.[4][20]
Consumer behavior & competition
During July–August 2025, approximately one in 10 U.S. adults reported taking a GLP-1 medication during the previous year, and about one in five GLP-1 users reported taking a compounded version. Competition is expanding across injectable and oral medicines, meal replacements, fitness services, telehealth and personalized coaching.[20][1]
M&A
Pfizer agreed in 2025 to acquire development-stage obesity-drug company Metsera for up to $86.25 per share, comprising $65.60 in cash and a contingent value right of up to $20.65 per share. The transaction followed a bidding contest involving Novo Nordisk and reflects pharmaceutical companies’ efforts to build obesity-drug pipelines.[21]
Regulation
The FDA approved Foundayo (orforglipron), an oral GLP-1 receptor agonist, on April 1, 2026, for chronic weight management in adults with obesity or overweight plus a weight-related condition. FDA-approved chronic weight-management indications generally require obesity or overweight with a related health condition, and compounded GLP-1 products are not reviewed by the FDA for safety, effectiveness or quality before marketing.[22][20]
Latest news
The most recent major development identified was the FDA’s April 1, 2026 approval of Foundayo, described by the agency as the first new molecular entity approved under its National Priority Voucher program. The once-daily tablet adds an oral GLP-1 option to the prescription weight-management market.[22]

02 Ranking

Top 10 Companies in the Weight Losing Industry

The leading companies in the weight losing industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 21, 2026 · Next review December 21, 2026

Verdict

Eli Lilly and Company stands out for obesity medicines because tirzepatide is marketed for obesity under the Zepbound brand, while Novo Nordisk focuses on obesity care since obesity care sales reached DKK 82 billion in 2025.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in obesity medicines

    Eli Lilly and Company

    US

    Ranked #1 · 9.7 · Obesity medicines

    Why we picked it: It sells obesity medicines under Zepbound and reported a 40.4% operating margin and 44.7% revenue growth.

  2. Leader in telehealth weight care

    Ro

    US

    Ranked #3 · 9.0 · Telehealth weight care

    Why we picked it: Its US telehealth model couples clinical guidance with medication access, supported by 66.3% revenue growth.

  3. Leader in digital behavioral weight programs

    Noom

    US

    Ranked #4 · 9.0 · Digital behavioral weight programs

    Why we picked it: It combines behavioral weight-management programming with medication access for users seeking both support modes.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the weight losing industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Eli Lilly and Company

Obesity medicines · US

9.7
2

Novo Nordisk

Obesity medicines · DK

9.3
3

Ro

Telehealth weight care · US

9.0
4

Noom

Digital behavioral weight programs · US

9.0
5

Hims & Hers Health

Direct-to-consumer medical weight management · US

8.8
6

Herbalife

Weight-management nutrition products, global · US

8.4
7

LifeMD

Virtual weight-management care and GLP-1 access, US · US

8.3
8

Calibrate

Employer and health-plan obesity management, US · US

8.2
9

WW International

Behavioral and clinical weight management, global · US

7.7
10

Medifast

Coach-guided weight-management program OPTAVIA, US · US

7.5

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 21, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 21). Top 10 companies in the weight losing industry. In Weight Losing Industry Statistics. Gitnux. https://gitnux.org/weight-losing-industry-statistics/#top-companies

report visual · Projection

Global healthy eating, nutrition, & weight loss market size

Global healthy eating, nutrition, & weight loss market size grew from $943.8B in 2020 to $1.2T in 2025.

$943.8B
Start
+4.65%
CAGR · 5y
$1.2T
Projected
20202025
source-verifiedglobalwellnessinstitute.org2025

04 Statistics

Market Intelligence

We see a services split between fitness-center and app-based offerings, with the global weight loss services market at $39.07 billion in 2025.

Market size and service revenue in the weight losing industry

  • $39.07 billion was the global weight loss services market in 2025, covering fitness centres and health clubs, digital weight-loss apps and other service types, according to Mordor Intelligence.[1]
  • $1.963 billion was U.S. revenue in 2024 for NAICS 812191 Diet and Weight Reducing Centers, defined as non-medical services helping clients attain or maintain a desired weight.[2]
  • $112.9 billion was the global 2024 market for weight loss products and services, a broader category including weight-management foods, beverages, supplements and services.[3]
  • $36.31 billion was the global weight loss services market in 2023, covering services segmented by function, payment method and region, according to Grand View Research.[4]

Growth forecasts for the weight losing industry

  • The global weight loss services market is projected to reach $29.47 billion in 2030 from $18.11 billion in 2025, at a 10.2% CAGR for 2025–2030.[5]
  • The global weight loss services market is projected to grow at a 7.6% CAGR from 2024 through 2030, reaching $60.48 billion in 2030.[4]
  • The global weight loss services market is projected to reach $60.48 billion by 2030 from $39.07 billion in 2025, implying a 7.6% CAGR for 2025–2030.[1]

Firm counts and size structure in the weight losing industry

  • 336 U.S. diet and weight reducing establishments had 10–19 employees in 2023.[6]
  • 1,592 U.S. diet and weight reducing establishments had fewer than five employees in 2023, representing the largest reported employment-size band.[6]
  • 2,481 employer establishments operated in the U.S. diet and weight reducing centers industry in 2023 under NAICS 812191.[6]
  • 494 U.S. diet and weight reducing establishments had 5–9 employees in 2023.[6]

Demand shifts in the weight losing industry

  • 31% of U.S. consumers reported following a weight-management program with a nutritionist as of November 2024.[7]
  • 29% of U.S. adults with weight-management experience cited nutrition support as a desired type of weight-loss support in the 2024 Rock Health survey series.[8]
  • 33% of U.S. adults with weight-management experience cited exercise support as a desired type of weight-loss support in the 2024 Rock Health survey series.[8]
  • 61% of 1,000 U.S. consumers wanted employers to offer weight health services in July 2024, including weight-management or weight-loss support.[9]

05 Statistics

Clients & Demand

Demand patterns skew toward remote delivery, with 81% of US coaching-service users accessing through virtual or hybrid channels during October 2023–May 2024.

Service penetration and outsourcing in the weight losing industry

  • 81% of U.S. respondents who had used or were using coaching services for weight loss accessed coaching through virtual or hybrid channels during October 2023–May 2024.[8]
  • 15% of U.S. respondents who had used or were using GLP-1s for weight loss accessed them through virtual channels during October 2023–May 2024.[8]
  • 31% of U.S. consumers trying to manage their weight had followed a weight-management program with a nutritionist, combining use in the past year and earlier use, in November 2024.[7]

06 Statistics

Pricing

Clinic pricing is clustered around a single monthly median, with $229 per month as the median advertised price across 490 observed prices in 2026.

Fees and price levels in the weight losing industry

  • $229 per month was the median advertised price across 490 monthly prices from 329 U.S. weight-loss clinics, observed in 2026; the middle half ranged from $150 to $399.[10]
  • Medi-Weightloss franchisees pay a royalty of 10% of gross sales or $2,250 per month, whichever is greater, under the U.S. 2025 franchise disclosure terms.[11]
  • $200 per month was the median advertised semaglutide price and $249 per month the median advertised tirzepatide price among U.S. weight-loss clinics, observed in 2026.[10]

07 Statistics

Finance

Cost structure expectations for weight-loss clinics are mixed, with Medi Weightloss assuming 75% gross-profit margin in 2024 and averaging 80% gross-profit margin across 57 reporting businesses.

Margins and profitability in the weight losing industry

  • 75% was the assumed gross-profit margin for Medi Weightloss in a 2024 U.S. health-and-wellness investment analysis.[12]
  • 80% was the average gross-profit margin for 57 Medi-Weightloss reporting businesses in the United States during fiscal year 2024.[13]
  • 23% was average net income before other expenses as a share of gross sales for 57 Medi-Weightloss reporting businesses in the United States during fiscal year 2024.[11]

Cost structure in the weight losing industry

  • 35% of gross sales was the average compensation, benefits and payroll-tax cost for 57 Medi-Weightloss reporting businesses in the United States during fiscal year 2024.[13]
  • 8% of gross sales was the average rent cost for 19 bottom-third Medi-Weightloss reporting businesses in the United States during fiscal year 2024.[13]
  • 20% of gross sales was the average cost-of-goods-sold ratio for 57 Medi-Weightloss reporting businesses in the United States during fiscal year 2024.[13]

08 Statistics

Risk & Compliance

Compliance requirements are state and federal, including Virginia staffing rules for advertising and HIPAA breach timelines such as 60 calendar days after discovering a breach.

Regulation and licensing in the weight losing industry

  • At least 1 full-time registered nurse is required for a Virginia weight-loss center to advertise physicians, doctors, patients or medical teams, under §18.2-502.1, current September 18, 2026.[14]
  • At least 1 physician licensed by Virginia’s Board of Medicine must be employed or contracted for qualifying weight-loss-center advertising, under §18.2-502.1, current September 18, 2026.[14]
  • Weight-loss controlled-substance prescriptions in Mississippi may not exceed a 30-day supply, under Rule 1.5(C) of the Mississippi Board of Medical Licensure’s administrative code, amended October 1, 2023.[15]

Client data and confidentiality in the weight losing industry

  • 180 days is the usual deadline for a client to file a HIPAA privacy or security complaint against a covered weight-loss provider after learning of the alleged violation.[16]
  • 500 affected individuals is the threshold triggering federal and, where applicable, media breach notification duties for HIPAA-covered weight-loss providers, under 45 CFR §164.408.[16]
  • 60 calendar days is the maximum deadline for HIPAA-covered weight-loss providers and business associates to notify affected individuals after discovering a breach of unsecured protected health information, under 45 CFR §§164.400–414.[16]

Key questions about the weight losing industry

What is the 2026 market size for weight management?
The global weight-management industry is estimated at $221.7 billion in 2026.
How fast is the market expected to grow from 2026 to 2033?
Grand View Research forecasts the market to reach $562.2 billion by 2033, implying a 14.2% CAGR from 2026 to 2033.
Which companies lead the weight losing industry?
Eli Lilly and Company stands out for obesity medicines because tirzepatide is marketed for obesity under the Zepbound brand, while Novo Nordisk focuses on obesity care since obesity care sales reached DKK 82 billion in 2025.
What technology shift is changing access in 2026?
The FDA approved Foundayo (orforglipron) on April 1, 2026, adding an oral once-daily GLP-1 receptor agonist option for chronic weight management.
How concentrated is the market structure for prescription-drug demand?
The prescription-drug segment is led by Eli Lilly and Novo Nordisk, with industry data tying concentration to their obesity portfolios.
What adoption barriers show up in the data for GLP-1 use?
CDC reporting identified cost and insurance coverage as important barriers, and about two in five U.S. GLP-1 users modified use from the prescribed regimen.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 21). Weight Losing Industry Statistics. Gitnux. https://gitnux.org/weight-losing-industry-statistics
MLA
Samuel Norberg. "Weight Losing Industry Statistics." Gitnux, 21 Nov 2026, https://gitnux.org/weight-losing-industry-statistics.
Chicago
Samuel Norberg. 2026. "Weight Losing Industry Statistics." Gitnux. https://gitnux.org/weight-losing-industry-statistics.